Metabolic syndrome is associated with increased complications and healthcare costs after adhesive capsulitis surgery

作者：Khela HS, Khela MS, Kelly JD 4th, Miller L · 发表于：Journal of shoulder and elbow surgery · 年份：2026 · DOI：10.1016/j.jse.2025.04.008 · 研究领域：Metabolic syndrome、adhesive capsulitis、healthcare costs、postoperative complications、secondary treatments、surgical outcomes

BACKGROUND: Metabolic disturbances are increasingly recognized as contributing factors in the development of adhesive capsulitis (AC). While metabolic syndrome (MetS) has been established as a risk factor for poorer surgical outcomes, there exist limited data on its impact on postoperative outcomes following surgical treatment for AC. The purpose of this study was to investigate the effects of MetS on complications and costs after surgery for AC. METHODS: A retrospective cohort analysis from 2011 to 2020 was conducted in the PearlDiver database. Patients with or without MetS who underwent arthroscopic capsular release and/or manipulation under anesthesia for AC were identified using International Classification of Diseases and Current Procedural Terminology diagnosis codes. Patients with active records 1 year prior to and 2 years after the initial diagnosis of AC were eligible. The MetS cohort was matched 1:1 to a control group without MetS based on age, sex, and Charlson Comorbidity Index. Total cost of care at various postoperative time points was compared between cohorts using Student's t-test. Multivariable logistic regression was performed to assess the impact of MetS on 90-day complications and secondary treatment utilization 2 years after surgery. A Bonferroni correction was applied to univariable analyses and multivariable regressions. RESULTS: The overall prevalence of MetS was 37.5% (n = 16,081) in a cohort of 42,862 patients undergoing AC surgery. After matching,...